INTRODUCTION
Despite advances in neonatal critical care medicine, mortality remains significant among neonates. The daily mortality rate during the neonatal period is almost 30-fold higher compared to the postneonatal period with the absolute highest risk of mortality occurring among preterm neonates (gestational age less than 37 weeks). 1 Infections including neonatal sepsis account for the greatest percentage of neonatal mortality worldwide, which exceeds 1 million neonatal deaths each year. 1 Bacteria are the predominant pathogens associated with neonatal sepsis with gram-negative bacteria accounting for 38 percent of neonatal septic shock cases and 63 percent of neonatal sepsis mortality. 2 To recognize and combat these life-threatening bacterial infections, neonates rely predominantly on their innate immune system. 3 As such, neutrophils play a crucial role in neonatal survival. Neutrophils act as early responders to pathogens and are the most predominant immune cells in human blood. 4 Despite their central role in the recognition and early response to infections, our understanding of human neonatal neutrophil function is limited. Recent advances have provided a unique opportunity to study low birth weight preterm population using whole-blood assays in the first few days of life. In the past, such studies would have been impossible to perform because of the required large blood volumes, which have now been overcome with the use of novel microfluidic approaches. 5 These approaches circumvent the need for neutrophil purification, thus allowing the investigation of neonatal neutrophils from a single 400 mL unprocessed whole-blood sample.
In addition, functional assays that utilize whole blood better reflect the intravascular milieu and thus should more closely approximate neutrophil capabilities in vivo. In this study, neutrophil chemotaxis and transcriptomics of both term and preterm neonates were characterized using whole-blood samples obtained in the first few days of life, as well as whole-blood samples from healthy young adults.
METHODS
Study design. This prospective observational study was conducted between February and September 2016 at UF Health Shands Children's Hospital, a 202-bed tertiary medical center. The study was approved by the Institutional Review Board before initiation and carried out according to The Code of Ethics of the World Medical Association (Declaration of Helsinki). All neonates admitted to the Neonatal Nursery and Neonatal Intensive Care Unit were screened for inclusion. Neonates born greater than 24 weeks gestational age were eligible for participation. Neonates were excluded from the study if the sample collection did not coincide temporally with a required clinical blood draw. Healthy adults aged 21-45 years were also recruited for participation. Adult subjects were excluded from enrollment if any of the following was reported: severe pre-existing organ dysfunction, positive for human immunodeficiency virus, recent use of oncolytics, current use of steroids, or history of autoimmune disease. Written informed consent was obtained from all adult subjects and from the parents of neonatal subjects before sample collection.
Sample collection. Whole-blood samples were collected from adults, term neonates, and preterm neonates. In adult subjects, a 4-mL blood sample was collected. In neonatal subjects, a single 700-mL blood sample was collected once at the time of a clinically required blood draw. Blood was collected for term neonates in the Neonatal Nursery before discharge between 24 and 36 hours of life. Blood was collected for preterm neonates in the Neonatal Intensive Care Unit on day 4 of life as not to interfere with the intense clinical management in the first 48 hours and to allow the family an appropriate time to absorb the trauma of a premature birth before discussing study enrollment.
Patient data collection. Patient data including maternal age, Group B streptococcal (GBS) colonization, prolonged premature rupture of membranes (PROM), clinical chorioamnionitis, antepartum AT A GLANCE COMMENTARY Raymond SL, et al.
Background
Neutrophils play a crucial role in combating lifethreatening bacterial infections in neonates. Despite their importance, our understanding of neonatal neutrophil function is limited. Recent advances in microfluidics have provided a unique opportunity to study this vulnerable population using small volume whole-blood samples.
Translational Significance
This study provides the first description of neutrophil chemotaxis and transcriptomics in both preterm and term neonates. These findings will aid in the development of reliable tests using microquantities of blood to diagnose defects in immune function, to evaluate potential therapies for infectious complications, and to establish criteria for which babies would benefit from these treatments.
antibiotics use, antepartum corticosteroid therapy, antepartum magnesium administration, labor, method of delivery, neonatal gender, completed gestational age, birth weight, Apgar scores, neonatal antibiotic administration, neonatal corticosteroid therapy, indomethacin administration, use of invasive respiratory therapy, positive blood cultures, and mortality were collected from the electronic medical records of the birth hospitalization. Prolonged PROM was defined as any rupture of membranes that persisted for more than 24 hours and before the onset of labor. The presence of labor was defined clinically by occurrence of contractions. Apgar scores were accessed at 1 and 5 minutes following birth by a certified pediatric nurse or physician. Neonatal antibiotics, corticosteroids, and indomethacin were recorded if administered any time before blood sample collection. Use of invasive respiratory therapy was based on the status of the neonate at the time of blood sample collection. Blood cultures were considered if drawn any time before blood sample collection and considered positive if the culture grew a microorganism. Mortality was defined as death during the birth hospitalization.
Neutrophil chemotaxis assay. Microfluidic chemotaxis devices with a single whole-blood loading chamber (WBLC), erythrocyte filters, and 16 identical migration tracks and focal chemoattractant chambers (FCCs) were used, as previously described and validated by Hoagn et al. and Jones et al. (Fig 1) . 5, 6 In brief, the filters block the dispersion of erythrocytes and monocytes into the migration channel, whereas actively migrating neutrophils can migrate through without a decrease in speed. A bifurcation before each FCC facilitates quantification of directional neutrophil movement following the chemoattractant gradient. Microfluidic chemotaxis devices were primed with the chemokine N-formylmethionyl-leucyl-phenylalanine (1 mM) (fMLP; Sigma-Aldrich, St. Louis, Mo). The device was then placed in a desiccator under vacuum for 10 minutes to ensure complete filling of the FCCs. Following filling, the WBLC and the outer region of the device were washed thoroughly with phosphatebuffered saline to establish a gradient along the migration tracks with the greatest concentration in the focal chemoattractant chambers. The device was then filled with Hank's Balanced Salt Solution (HBSS) with albumin and allowed to sit for a period of 10 minutes to generate a stable chemoattractant gradient. Finally, 2 mL of whole blood stained with Hoechst Stain Solution (Sigma-Aldrich, St. Louis, Mo) was pipetted into the WBLC. Time-lapse imaging was performed every 30 seconds for 10 hours on a Nikon Bio-Station IMq microscope inside of a biochamber heated to 37 C with 5% CO 2 . Neutrophil percent migration was calculated using Nikon Imaging Software Elements High Content Analysis (Nikon Instruments Inc, Melville, NY). Neutrophil instantaneous velocity and directionality were calculated using ImageJ software (NIH, Bethesda, Md). 7 Neutrophil transcriptome assay. Neutrophils were captured from 350 ml of whole blood using positive selection with anti-CD66b monoclonal antibody, clone 80H3 (BioRad, Hercules, Calif) coated microfluidic devices as previously described and validated by Kotz et al., Warner et al., and Mathias et al. [8] [9] [10] The microfluidic devices capture a fixed number of neutrophils, thus the total number of neutrophils captured were equivalent among groups regardless of any differences in total or differential counts. Captured neutrophils were lysed en bloc using RLT buffer (Qiagen, Valencia, Calif). The cell lysate was passed through a QiaShredder column, and RNA was extracted from lysates using QIAGEN RNeasy Mini Kit (Qiagen). RNA integrity was assessed with an Agilent 2100 Bioanalyzer (Santa Clara, Calif). RNA was labeled using Nugen Ovation Pico WTA System V2 (NuGEN Technologies, Inc, San Carlos, Calif). Resulting cDNA was labeled and fragmented using Nugen Encore Biotin Module, hybridized onto GeneChip Human Transcriptome Array 2.0 (Affymetrix, Santa Clara, Calif) and processed following manufacturer's instructions. Genome-wide expression was normalized using RMA as implemented in Partek Genomics Suite, Version 6.6 (Partek Inc, St. Louis, Mo).
Statistical analysis. Patient data for samples in the neutrophil chemotaxis assay and transcriptome assay were assigned to term and preterm neonatal groups based on gestational age. Statistical analyses for subject data and functional analyses were performed using Prism GraphPad Software (La Jolla, Calif). Two-tailed Student's t tests and Fischer's exact tests were used to compare continuous and categorical clinical variables, respectively. Mann-Whitney U test was utilized for nonparametric data. For each neutrophil chemotactic measurement (percent cell migration, neutrophil velocity, and directionality), means and standard deviations were calculated and compared among adults, term neonates, and preterm neonates by use of a 2-tailed Student's t test with Bonferroni correction.
Genome-wide expression was compared among adults, term neonates, and preterm neonates using both unsupervised and supervised analyses. In the unsupervised analysis, probe sets with a coefficient of variation greater than 50% were hierarchically clustered. Hierarchical clustering was generated using DNA-Chip Analyzer (dChip) software. In the supervised analysis, significant genes were identified using an F-test at P , 0.001. Leave-one-out cross-validation and Monte Carlo simulations and permutation analysis were used to determine whether the misclassification rate for each subject (term, preterm, or adult) was significantly better than predicted by chance, using BRB ArrayTools, Version:4.5.1-Stable Release as described previously. [11] [12] [13] Once significant genes were identified, Gene Ontology analysis was conducted as implemented in BRB ArrayTools. Fold changes of significant genes were calculated between groups. Functional pathway analysis was performed on significant genes using Ingenuity Pathway Analysis (IPA) software (Ingenuity Systems, Redwood City, Calif). IPA predicts significant canonical pathways, common upstream transcriptional regulators, and cellular functions based on the expression values from a group of genes and prior knowledge of expected effects of these gene products. Significance pathways were determined using a z-score greater than 2 or less than 22.
RESULTS
Patient data. Whole-blood samples were collected from 15 young adults (21-45 year old), 20 term neonates (gestational age .37 weeks), and 20 preterm neonates (gestational age ,37 weeks). Small sample volumes and technical issues prevented all measurements to be performed for every subject. The exact number of subjects for each experiment is given in the figure legends. Patient data regarding demographics, management, and outcomes are provided in Tables I and II . Overall, there was a slight predominance of male neonates in the study cohort (55%). Sixty-three percent of neonates were born via cesarean section. Mean maternal age was 28 years with 41% of the mothers being positive for GBS. Method of delivery, gender, maternal age, and GBS colonization were similar between preterm and term neonatal groups. Mothers of preterm neonates had a greater incidence of prolonged PROM, clinical chorioamnionitis, and labor. Mothers of preterm neonates were also more likely to receive antepartum antibiotics, corticosteroids, and magnesium. Overall, term neonates had an average completed gestational age of 39 weeks, whereas preterm neonates had an average completed gestational age of 29 weeks. Preterm neonates had mean birth weight of 1457 g, which was significantly less than term neonates at 3325 g. Preterm neonates were also born with significantly lower Apgar scores at 1 and 5 minutes, compared to term neonates. Furthermore, preterm neonates were more likely to receive mechanical ventilation and to be administered antibiotics and indomethacin. There were no neonates with positive blood cultures within the first 96 hours of life. Finally, there were no neonatal deaths during the birth hospitalization. Neutrophil chemotaxis. Ex vivo whole blood chemotaxis was measured to the chemokine fMLP for term and preterm neonates, as well as young adults. A representative time-lapse video of the 10-hour measurement is presented in the Supplemental material section. The mean number of cells added to each device was not significantly different among groups (adult 1036 cells, term 1039 cells, preterm 1343 cells; P 5 0.2693). One in 8 neutrophils from preterm neonates successfully migrated to fMLP over 10 hours, compared to approximately 1 in 3 neutrophils from term neonates (preterm 12.3%, term 30.5%; P 5 0.008) (Fig 2, A and B) . Percent neutrophil migration in term neonates was greater, albeit not significantly from adults (term 30.5%, adult 22.2%; P 5 0.36). The velocity of neutrophils from preterm neonates that migrated to fMLP was significantly lower than that of adult neutrophils (preterm 10.1 mm/min, adult 12.7 mm/min; P 5 0.003; Fig 2C) , while the velocity of neutrophils from term neonates was intermediate (11.3 mm/min). Despite fewer neutrophils migrating at slower velocities, the capability of neutrophils from preterm neonates to follow the fMLP gradient (directionality index) was comparable to neutrophils from adults or term neonates (Fig 2D) . Neutrophil transcriptomics. To determine if the observed differences in neutrophil chemotaxis to fMLP were reflected by changes in the neutrophil transcriptome, genome-wide expression of CD66b 1 -captured cells was performed. An unsupervised analysis of gene expression from the 3 groups identified 2077 genes that were differentially expressed among the 3 groups with a coefficient of variation greater than 50%. When the 2077 genes were hierarchically clustered based on the overall similarity of the expression without any knowledge of the group assignment, the expression pattern could distinguish preterm neonates from term neonates and young adults (Fig 3A) . Following the first major division in the dendrogram, term neonates and young adults further separated into 2 distinct groups. The overall clustering was not perfect as the expression pattern of 1 term neonate clustered with the preterm neonates, and the expression pattern of 1 preterm neonate clustered with the term neonates. Further review of the electronic medical records for the birth hospitalization of these 2 subjects did not identify any specific differences unique to these 2 neonates compared to the other neonates in their respective groups.
Using a supervised analysis, the expression of 3607 genes significantly differed among the 3 groups at a confidence level of P , 0.001. Hierarchical clustering of these genes was similar to the previous unsupervised analysis with the gene expression patterns between young adults and term neonates being more similar to each other than to preterm neonates (Fig 3B) . Again, 1 term neonate incorrectly clustered with the preterm neonates in the supervised analysis.
Cross-validation methods were able to distinguish subjects by group with a mean percent of correct classification of 90% and 83% for 1-nearest neighbor classifier and 3-nearest neighbor classifier, respectively. The misclassification rate was significantly better than predicted by chance based on Monte Carlo simulations using 1000 random permutations (P , 0.001).
Compared to adults, preterm neonates had 500 genes differentially expressed with greater than a 2-fold difference (P , 0.001), whereas term neonates had 205 genes that were differentially expressed compared to adults (P , 0.001, .2-fold difference). One hundred twenty-five genes were differentially expressed in both preterm and term neonates compared to adults (P , 0.001, .2-fold difference). Compared to term neonates, 113 genes were differentially expressed in preterm neonates (P , 0.001, .2-fold difference). The genes with the greatest downregulation in preterm neonates compared to term neonates or young adults included key components of innate immune response to pathogens: peptidase inhibitor 3 (PI3, an antimicrobial peptide); pro-platelet basic protein (PPBP, a chemoattractant and neutrophil activator); C-type lectin domain family 2, member B (CLEC2B, role in pathogen recognition), guanylate binding protein 1 (GBP1, promotes antimicrobial activity); and ribonuclease RNase A family, k6 (RNASE6, a broad-spectrum antimicrobial protein) (Table III) .
Functional pathway analysis. To better understand the biologic differences, the 3607 differentially expressed genes were examined using IPA. Preterm neonates had significant downregulation in the canonical pathways . When 2077 genes with a coefficient of variation .50% were hierarchically clustered, differences in the patterns of gene expression were revealed among young adults, term neonates, and preterm neonates. The dendogram above the hierarchical clustering summarizes the Pearson correlations. The length of each branch is equivalent to (1-R), so that small branches indicate high correlation coefficients in expression among branches at that level. The first branch indicates the clusters that are more closely related, and in this case, is between adults and term neonates, indicating that their gene expressions are more closely to each other than they are to the expression of preterm neonates. (B) Supervised analysis hierarchical clustering (3607 genes). Using a supervised analysis, the expression of 3607 genes significantly differed among the 3 groups (P , 0.001). The significant genes were then hierarchically clustered, and the dendograms show the clustering based on the Pearson correlations. Based on this supervised analysis, the gene expression patterns between young adults and term neonates were again more similar to each other than to preterm neonates.
for ''interleukin (IL)-1 signaling'', ''inducible nitric oxide synthase (iNOS) signaling'', and ''inflammasome pathway'', compared to term neonates (z-score ,22) (Fig 4) . Preterm neonates also had significant inhibition of the common upstream transcriptional regulators for the cytokines CXCL12, IL1A, IL1B, IL12A, IFNB1, IFNG, OSM, MIF, TNF, and TNFS10, compared to term neonates (z-score ,22) (Table IV) . Furthermore, preterm neonates had significant inhibition of upstream regulators for the primary inflammatory regulator, nuclear factor-kB (NF-kB) complex, and toll-like receptor 2 (TLR2), compared to term neonates (z-score ,22). Genes involved in ''cell movement of neutrophils'' and in ''phagocytosis'' were surprisingly not significantly different between preterm and term neonates (z-scores 1.34 and 0.487, respectively). Interestingly, these genes were significantly increased in both preterm and term neonates compared to adults (z-score .2), again consistent with the reliance on innate immunity by neonates.
In comparison to young adults, both preterm and term neonates had inhibition of upstream transcriptional regulators for interferon beta 1 (IFNB1) and the classic T-cell transmembrane receptors CD3 and CD28 consistent with decreased role for adaptive immunity in neonates (z-score ,22) (Table V) . Both preterm and term neonates had significant activation of upstream regulators of multiple cytokines including CXCL8, IL1B, IL2, IL4, IL5, and IL6, compared to young adults consistent with their reliance on innate immunity (z-score .2).
Finally, cellular function analysis revealed preterm neonates specifically had underexpression of genes involved in ''differentiation of blood cells and leukocytes'', compared to term neonates (z-score ,22) (Supplemental Table 1 ). Both preterm and term neonates had significant underexpression of genes involved in cell death, necrosis, and apoptosis, and significant overexpression of genes involved in cell viability, cellular growth, and cell survival, compared to adults (z-score ,2).
DISCUSSION
Sepsis remains a prominent cause of neonatal mortality especially among preterm neonates. Previous studies have demonstrated that neonatal neutrophils specifically have qualitative impairments of adherence, chemotaxis, phagocytosis, neutrophil respiratory burst activity, and release of extracellular traps, compared to adults. [14] [15] [16] [17] [18] [19] [20] [21] However, these findings have been largely based on experiments that utilized cord blood from term neonates and required detailed neutrophil isolation. Here, we focused on neutrophil chemotaxis and transcriptomics of both preterm and term neonates utilizing whole-blood samples obtained from the neonates themselves in the first few days of life. The chemotactic measurements obtained here cannot be achieved using any of the traditional cell migration technologies, including the commonly used transwell assay. 22 Transwell assays provide only end-point results for populations of cells and lack single cell resolution. In addition, transwell assays require several million neutrophils isolated from at least 5 mL of whole blood, which is not possible to collect in extremely low-birth weight neonates where total blood volumes may be less than 100 mL. 23 We demonstrate that preterm neonates have inherent defects in neutrophil migration in response to a microbial product, whereas neutrophil migration in term neonates was not significantly different from adults. Subsequently, we asked whether changes in neutrophil transcriptome could explain the functional changes associated with preterm neonates. A survey of the published literature found no studies looking at genome-wide expression of neutrophils from preterm and term neonates. Here, we demonstrate that preterm neonates have significant differences in gene expression compared to term neonates and young adults. Analysis of the most downregulated genes suggests that at the transcriptional level, preterm neonates have a generalized, diminished ability to mount a successful innate immune response compared to term neonates or young adults. Subsequent functional genomic analysis revealed that preterm neonates also had deficiencies in pathogen recognition and pathogen destruction, compared to term neonates, as demonstrated by inhibition of the IL-1 signaling, iNOS signaling, and inflammasome pathway. [24] [25] [26] Preterm neonates also had inhibition of upstream regulators for multiple cytokines, NF-kB, and TLR2, compared to term neonates. NF-kB is a central regulator of innate immunity and inflammation and plays a role in neutrophil development and survival. 27 TLR2 is important for the recognition of gram-positive and gram-negative bacteria. 28 As demonstrated by these findings, preterm neonates have significant deficiencies in the neutrophil transcriptome for the innate arm of the host protective immune response, when compared to term neonates.
In comparison to healthy young adults, both preterm and term neonates had inhibition of key promoters for T-cell activation. 29 Although the expression of these T-cell genes is not significant in neutrophils, the observation that their upstream transcriptional regulators are suppressed in neonates suggests that they are likely to have defects in the regulation of gene expression in adaptive immunity. This supports previous studies which have demonstrated neonates fail to produce a robust adaptive immune response to infection. 30 Likewise, it is well known that neutrophils communicate bidirectionally with the adaptive immune response through neutrophil development and the expression of regulatory cytosolic and cell surface molecules. Compared to healthy young adults, preterm and term neonates had significant activation in transcriptional regulators for various cytokines including IL-6, which has been shown to have anti-inflammatory properties and inhibit neutrophil accumulation at sites of inflammation. 31 Neonates also had significant downregulation of genes involved in cellular death and upregulation of genes involved in cellular growth, compared to adults. These findings are not unexpected since neonates are in a period of rapid growth and development and are consistent with our previous work comparing the transcriptome of na€ ıve neonatal mice and healthy young adult mice. 32 There are number of limitations to the study that require further discussion. First, the relatively small number of study participants are underpowered to detect all significant differences between young adults, term neonates, and preterm neonates. However, the study had at least 80% power to find a difference in the percentage of neutrophils migrating if one exists and 5% chance that the differences would not be observed if the number of patients enrolled were increased. Second, the neonatal population was heterogeneous with preterm neonates being born at lower birth weights and Apgar scores compared to term neonates. However, this is expected given the differences in gestational age. Preterm neonates were more likely to be exposed to prolonged premature rupture of membranes, clinically suspected chorioamnionitis, and labor, compared to term neonates. Prior studies have suggested microbial exposure and labor may have influential roles in neutrophil function. Specifically, some investigators believe that neonatal neutrophils reside in a ''preprimed'' state and become reactive following labor. 33 Despite preterm neonates being exposed to these potentially activating factors, preterm neutrophils still demonstrated deficiencies in chemotaxis and transcriptomics.
In the study cohort, preterm neonates were also more likely to be administered antibiotics following birth given their prematurity. The use of broad-spectrum antibiotics in preterm neonates is known to be associated with microbiome modification and decreased microbial diversity, which may have global effects on neonatal health. 34 Changes in the microbiome may specifically influence neutrophil chemotaxis. For example, previous murine studies have demonstrated that the microbiota drives neutrophil ageing and that aged neutrophils have reduced capacity for migration to site of inflammation. 35, 36 We recommend future studies investigating the human neonatal intestinal microbiome and its impact on neutrophil function.
Since electronic medical records were only reviewed for neonatal subjects, maternal characteristics, such as presence of labor and antenatal medication administration, are subject to reporting bias in the neonates' record. In addition, this study was not designed to directly access the impact of medications on neonatal neutrophil migration; however, previous cord blood studies investigating isolated neutrophil migration to zymosan-activated serum demonstrated defective chemotaxis with betamethasone and magnesium sulfate exposure. 37, 38 The presence and duration of these effects in vivo remains unknown. Herein, samples from term neonates were collected at the same time as blood for the state's newborn screening program and occurred between 24 and 36 hours of life because of the current practice of rapid discharge of healthy term newborns. In contrast, samples from preterm neonates were delayed until day four of life, primarily out of respect for the family dealing with the trauma of a premature birth, as well as the intense clinical management commonly required in the first 48 hours. This delay may additionally allow antenatal medications to be cleared from the neonatal circulation, as well as minimize the influence of the physiological stresses from labor and delivery on the observed neutrophil chemotaxis and transcriptomics.
The small volume of whole blood collected for neonatal subjects prevented additional assessments of neutrophil function, such as phagocytosis, oxidative burst, and bacterial killing. Likewise, the time-lapse imaging microscope and microfluidic chemotaxis device design permit only 1 chemoattractant to be studied during a given chemotaxis assay, thus fMLP was the only chemoattractant used here. Regarding the neutrophil transcriptome assay, anti-CD66b monoclonal antibody coated microfluidic device were utilized; however, it is important to note that CD66b is expressed on other granulocyte subsets including eosinophils. 39 Nevertheless, neutrophils comprise the majority of the CD66b positive population. A previous validation study comparing the microfluidic technique used herein to neutrophil isolation by dextran-Ficoll demonstrated the biological and analytical artifacts introduced by microfluidics processing are small and possibly less than the variability among subjects or due to dextran-Ficoll isolation. 9 Furthermore, microfluidic approaches may result in the introduction of less artifactual ex vivo stimulation, as it requires significantly fewer sample manipulations and less exposure to nonphysiologic solutions and g forces. RNA hybridization-based microarrays have general limitations as well. Specifically, their ability to make predictions of the overall genome is restricted to gene-level, although the GeneChip Human Transcriptome Array 2.0 contains probe sets for future exon-level and alternative splicing determinations. 40 Although predicted canonical pathways and regulatory networks can provide a representation of molecular interactions within cells, the actual regulatory pathways are dynamic and change with environmental stresses. 41 Despite the study limitations, the authors feel that the results are applicable and represent the first time microfluidic techniques were used to analyze neutrophil chemotaxis and transcriptomics from the whole blood of preterm and term neonates.
In conclusion, we demonstrated that preterm neonates have significant differences in neutrophils, compared to term neonates and young adults. These differences include reduced percent neutrophil migration and velocity in response to a microbial product, as well as transcriptomic evidence of impaired pathogen recognition, cytokine production, and anti-microbial activity. These findings suggest that the defects in neutrophil migration may be just one component of a more generalized transcriptional downregulation of promoters and genes involved in inflammation and innate immunity. Future studies should focus on investigating the impact of specific maternal and neonatal factors, as well the development of targeted interventions aimed at enhancing neutrophil function in preterm neonates with the ultimate goal of developing therapies to prevent and treat neonatal sepsis.
